Variants in clock genes could be associated with lower risk of type 2 diabetes in an elderly Greek population.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 25 01 2021
revised: 16 06 2021
accepted: 06 07 2021
entrez: 22 10 2021
pubmed: 23 10 2021
medline: 17 11 2021
Statut: ppublish

Résumé

Recent evidence has linked circadian rhythm dysregulation to an increased risk of metabolic disorders. This study explores a potential association between variation in genes regulating the endogenous circadian timing system (clock genes) and the risk of type 2 diabetes (T2D) in a sample of Greek elderly people. Variants within and upstream or downstream of PPARA, PPARD, CLOCK/TMEM165, PER1, PER2 and PER3 genes were genotyped in 716 individuals with T2D (A) and 569 normoglycemic controls (B), and allele frequencies were compared between the groups in a case control study design. Samples were genotyped on Illumina Human PsychArray. Permutation test analysis was implemented to determine statistical significance. To avoid the possibility of subjects with prediabetes being included in the control group, people with HbA1c <5.7% and fasting glucose <100 mg/dl comprised group C (n = 393), for whom a separate analysis was performed (secondary analysis). A protective role against T2D was identified for 14 variants in the PPARA gene. The rs7291444, rs36125344, rs6008384 in PKDREJ, located upstream of PPARA, and rs2859389 in UTS2, located upstream of PER3, demonstrated a protective role against T2D in both analyses. In contrast, rs6744132, located between HES6 and PER2, was positively correlated with T2D risk. Only in the secondary analysis, rs2278637 in VAMP2, located downstream of PER1, and rs11943456 in CLOCK/TMEM165 were found to confer protection against T2D. In a recessive model analysis of all groups, PPARD variants exhibited a protective role against disease. Our findings suggest a possible implication of clock genes in T2D susceptibility. Further studies are needed to clarify the mechanisms that connect circadian rhythm dysfunction and T2D pathogenesis.

Identifiants

pubmed: 34674804
pii: S0378-5122(21)00124-9
doi: 10.1016/j.maturitas.2021.07.004
pii:
doi:

Substances chimiques

Antiporters 0
Cation Transport Proteins 0
TMEM165 protein, human 0
CLOCK Proteins EC 2.3.1.48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-25

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Xanthippi Tsekmekidou (X)

Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.

Fotis Tsetsos (F)

Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.

Theocharis Koufakis (T)

Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.

Marianthi Georgitsi (M)

1st Laboratory of Medical Biology-Genetics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.

Nikolaos Papanas (N)

Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.

Dimitrios Papazoglou (D)

Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.

Athanasios Roumeliotis (A)

Division of Nephrology and Hypertension, First Department of Internal Medicine, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.

Stylianos Panagoutsos (S)

Department of Nephrology, Alexandroupolis University General Hospital, Democritus University of Thrace School of Health Sciences.

Elias Thodis (E)

Department of Nephrology, Alexandroupolis University General Hospital, Democritus University of Thrace School of Health Sciences.

Marios Theodoridis (M)

Department of Nephrology, Alexandroupolis University General Hospital, Democritus University of Thrace School of Health Sciences.

Ploumis Passadakis (P)

Department of Nephrology, Alexandroupolis University General Hospital, Democritus University of Thrace School of Health Sciences.

Efstratios Maltezos (E)

Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.

Peristera Paschou (P)

Department of Biological Sciences, Purdue University, West Lafayette, IN, United States.

Kalliopi Kotsa (K)

Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece. Electronic address: kkalli@auth.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH